Published in Curr Opin Hematol on September 01, 1995
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 7.31
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med (1995) 6.86
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med (1991) 4.66
Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med (2001) 2.89
Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood (2000) 2.78
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost (2015) 2.46
A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol (1992) 2.18
The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med (1994) 2.09
Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med (1993) 2.08
Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol (1995) 2.07
High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med (1997) 2.05
A 14-year study of heparin-induced thrombocytopenia. Am J Med (1996) 2.03
A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol (1995) 2.01
The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med (1997) 2.00
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost (2008) 1.75
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation (2001) 1.64
A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (1993) 1.52
Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia. J Lab Clin Med (1997) 1.51
Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med (1996) 1.48
Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity. J Clin Invest (1978) 1.43
Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol (1990) 1.43
A novel congenital haemostatic defect: combined factor VII and factor XI deficiency. Blood Coagul Fibrinolysis (1992) 1.42
A Canadian hospital-based HIV/hepatitis C look-back notification program. CMAJ (1997) 1.38
Heparin-associated thrombocytopenia. Ann Intern Med (1984) 1.35
Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med (2001) 1.30
Immune-mediated thrombocytopenia of malaria. J Clin Invest (1983) 1.28
A diagnostic test for heparin-induced thrombocytopenia. Blood (1986) 1.27
Gestational thrombocytopenia. Clin Obstet Gynecol (1999) 1.24
A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood (1982) 1.21
Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol (2000) 1.19
Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood (1981) 1.14
Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol (1990) 1.12
Infection-induced thrombocytopenia. Semin Thromb Hemost (1982) 1.10
A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost (2013) 1.10
The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood (1982) 1.10
Clinical impact of neonatal thrombocytopenia. J Pediatr (1987) 1.09
Heparin-induced thrombocytopenia. Annu Rev Med (1989) 1.08
A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol (1999) 1.08
Autoimmune platelet destruction: idiopathic thrombocytopenic purpura. Semin Thromb Hemost (1982) 1.07
Elevated platelet-associated IgG in the thrombocytopenia of septicemia. N Engl J Med (1979) 1.06
Vaccination-Associated relapse of immune thrombocytopenia. JAMA (1981) 1.06
The direct assay for platelet-associated IgG (PAIgG): lack of association between antibody level and platelet size. Blood (1979) 1.05
Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv (1993) 1.04
Digitalis toxicity manifested by dysphagia. JAMA (1978) 1.02
The use of in vitro technics to study drug-induced pancytopenia. N Engl J Med (1979) 1.01
Heparin-induced thrombocytopenia. Prog Hemost Thromb (1991) 1.01
Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med (1988) 1.00
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood (2000) 1.00
Neonatal thrombocytopenia due to passive immunization: prenatal diagnosis and distinction between maternal platelet alloantibodies and autoantibodies. N Engl J Med (1980) 1.00
Heparin and platelets. Hematol Oncol Clin North Am (1990) 0.99
Bleeding associated with antithrombotic therapy. Semin Hematol (1980) 0.98
Antiplatelet agents: rationale and results. Clin Haematol (1983) 0.98
Comparison of chemical composition of peritoneal fluid and serum: a method for monitoring dialysis patients and a tool for assessing binding to serum proteins in vivo. Ann Intern Med (1978) 0.97
Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood (1980) 0.94
Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management. Blood Rev (1996) 0.94
Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood (2001) 0.94
The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol (1996) 0.90
p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem (1991) 0.90
Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med (1992) 0.89
The relationship among platelet-associated IgG, platelet lifespan, and reticuloendothelial cell function. Blood (1984) 0.89
Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopenia. Blood (1980) 0.89
Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol (1993) 0.88
A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol (1987) 0.88
Management of the pregnant patient with idiopathic thrombocytopenic purpura. Ann Intern Med (1983) 0.87
111In-oxine platelet survivals in thrombocytopenic infants. Blood (1987) 0.87
Valproic acid and thrombocytopenia. Can Med Assoc J (1981) 0.87
Thrombocytopenia in preeclampsia and eclampsia. Semin Thromb Hemost (1982) 0.87
Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b). Blood (1992) 0.86
Studies on the frequency of heparin-associated thrombocytopenia. Thromb Res (1984) 0.86
Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol (1990) 0.86
Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex. Kidney Int (2007) 0.85
Investigation of human platelet alloantigens and glycoproteins using non-radioactive immunoprecipitation. J Immunol Methods (1993) 0.85
Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest (1993) 0.85
Perinatal thrombocytopenia. Clin Perinatol (1995) 0.85
Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood (1991) 0.85
Multimerin: a series of large disulfide-linked multimeric proteins within platelets. Blood (1991) 0.85
Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders. N Engl J Med (1987) 0.85
The development and application of a serum assay for platelet-bindable IgG (S-PBIgG). J Lab Clin Med (1981) 0.85
Substitution of the "group-and-screen" for the full crossmatch in elective operations. Can Anaesth Soc J (1983) 0.84
The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost (2009) 0.84
A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol (1996) 0.84
The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia. Blood (1983) 0.84
Methyldopa-induced autoantibodies against red blood cells. Blood Rev (1988) 0.84
Idiopathic immune thrombocytopenic purpura: an update. Semin Hematol (2000) 0.84
Quantitation of red cell-associated IgG using an immunoradiometric assay. Transfusion (1985) 0.84
Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin. Thromb Res (1981) 0.83
Inappropriate antidiuretic hormone complicating histiocytic lymphoma. Arch Intern Med (1979) 0.83
Platelet transfusions. Can Med Assoc J (1979) 0.83
The concentration of IgG in the serum is a major determinant of Fc-dependent reticuloendothelial function. Blood (1985) 0.83
Quantitation of red cell membrane associated immunoglobulin in children with Plasmodium falciparum parasitaemia. Br J Haematol (1983) 0.83
Current concepts in the treatment of immune thrombocytopenia. Drugs (1990) 0.83
Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Br J Haematol (1998) 0.83
FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia. J Thromb Haemost (2013) 0.83
The quantitation of platelet-associated IgG on cohorts of platelets separated from healthy individuals by buoyant density centrifugation. Blood (1982) 0.82
Heparin-induced thrombocytopenia. Haemostasis (1986) 0.82
Eradication of Rh hemolytic disease of the newborn. Can Med Assoc J (1980) 0.82